Home » GSK ANNOUNCES RESUPPLY OF PAXIL CR TO U.S. MARKET
GSK ANNOUNCES RESUPPLY OF PAXIL CR TO U.S. MARKET
June 27, 2005
GlaxoSmithKline has announced the availability of Paxil CR (paroxetine HCl controlled release) tablets in pharmacies across the U.S. Other markets will follow shortly thereafter. GSK committed to resupplying pharmacies and wholesalers by midyear after disruption of supply following the company's voluntary withdrawal of the product in February due to manufacturing issues. Both the company and the U.S. Food and Drug Administration (FDA) agreed at the time that the manufacturing issues posed no significant safety issues for patients.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20450220&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct